A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
Name
Valastyan-2009-A Pleiotropically Ac.pdf
Size
2.57 MB
Format
Adobe PDF
Checksum (MD5)
58c55ad9c920f1d59d2527893e6530b6
Author(s)
Valastyan, Scott John
Reinhardt, Ferenc
Benaich, Nathan
Calogrias, Diana
Szász, Attila M.
Wang, Zhigang C.
Brock, Jane E.
Richardson, Andrea L.
Nathan Benaich
Weinberg, Robert A
Date Issued
June 2009
Journal
Cell
Publisher
Elsevier B.V.
Citation
Valastyan, Scott, Ferenc Reinhardt, Nathan Benaich, Diana Calogrias, Attila M. Szász, Zhigang C. Wang, Jane E. Brock, Andrea L. Richardson, and Robert A. Weinberg. “A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis.” Cell 137, no. 6 (June 2009): 1032–1046. © 2009 Elsevier Inc.
Version
Final published version
Abstract
MicroRNAs are well suited to regulate tumor metastasis because of their capacity to coordinately repress numerous target genes, thereby potentially enabling their intervention at multiple steps of the invasion-metastasis cascade. We identify a microRNA exemplifying these attributes, miR-31, whose expression correlates inversely with metastasis in human breast cancer patients. Overexpression of miR-31 in otherwise-aggressive breast tumor cells suppresses metastasis. We deploy a stable microRNA sponge strategy to inhibit miR-31 in vivo; this allows otherwise-nonaggressive breast cancer cells to metastasize. These phenotypes do not involve confounding influences on primary tumor development and are specifically attributable to miR-31-mediated inhibition of several steps of metastasis, including local invasion, extravasation or initial survival at a distant site, and metastatic colonization. Such pleiotropy is achieved via coordinate repression of a cohort of metastasis-promoting genes, including RhoA. Indeed, RhoA re-expression partially reverses miR-31-imposed metastasis suppression. These findings indicate that miR-31 uses multiple mechanisms to oppose metastasis.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Whitehead Institute for Biomedical Research
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1016/j.cell.2009.03.047
